These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 34482698)
1. Discovery of a Long-Acting Parathyroid Hormone 1-34 Analogue to Treat Hypoparathyroidism. Ruan S; Yang G; Dong Y; Shangguan W; Lu W Mol Pharm; 2021 Sep; 18(9):3260-3271. PubMed ID: 34482698 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study. Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860 [TBL] [Abstract][Full Text] [Related]
3. Hypoparathyroidism: is it that easy to treat? Triantafyllou E; Yavropoulou MP; Anastasilakis AD; Makras P Hormones (Athens); 2019 Mar; 18(1):55-63. PubMed ID: 29876797 [TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic Actions of a Long-Acting PTH Analog (LA-PTH) in Thyroparathyroidectomized (TPTX) Rats and Normal Monkeys. Shimizu M; Joyashiki E; Noda H; Watanabe T; Okazaki M; Nagayasu M; Adachi K; Tamura T; Potts JT; Gardella TJ; Kawabe Y J Bone Miner Res; 2016 Jul; 31(7):1405-12. PubMed ID: 26865415 [TBL] [Abstract][Full Text] [Related]
5. [Reduction in requirements of oral calcium and 1-25 dihydroxy vitamin D in patients with post-surgical hypoparathyroidism treated with teriparatide (PTH1-34)]. Gutiérrez-Cerecedo LE; Vergara-López A; Rosas-Barrientos JV; Guillén-González MÁ Gac Med Mex; 2016; 152(3):322-8. PubMed ID: 27335186 [TBL] [Abstract][Full Text] [Related]
6. PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment. Sikjaer T; Amstrup AK; Rolighed L; Kjaer SG; Mosekilde L; Rejnmark L J Bone Miner Res; 2013 Oct; 28(10):2232-43. PubMed ID: 23649554 [TBL] [Abstract][Full Text] [Related]
7. Drug safety evaluation of parathyroid hormone for hypocalcemia in patients with hypoparathyroidism. Marcucci G; Della Pepa G; Brandi ML Expert Opin Drug Saf; 2017 May; 16(5):617-625. PubMed ID: 28332412 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study. Mannstadt M; Clarke BL; Vokes T; Brandi ML; Ranganath L; Fraser WD; Lakatos P; Bajnok L; Garceau R; Mosekilde L; Lagast H; Shoback D; Bilezikian JP Lancet Diabetes Endocrinol; 2013 Dec; 1(4):275-83. PubMed ID: 24622413 [TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of PTH 1-34 and 1-84 Therapy in Chronic Hypoparathyroidism: A Meta-Analysis of Prospective Trials. Puliani G; Hasenmajer V; Simonelli I; Sada V; Pofi R; Minnetti M; Cozzolino A; Napoli N; Pasqualetti P; Gianfrilli D; Isidori AM J Bone Miner Res; 2022 Jul; 37(7):1233-1250. PubMed ID: 35485213 [TBL] [Abstract][Full Text] [Related]
10. Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism. Winer KK; Zhang B; Shrader JA; Peterson D; Smith M; Albert PS; Cutler GB J Clin Endocrinol Metab; 2012 Feb; 97(2):391-9. PubMed ID: 22090268 [TBL] [Abstract][Full Text] [Related]
11. Quality of life in hypoparathyroidism. Vokes T Bone; 2019 Mar; 120():542-547. PubMed ID: 30261328 [TBL] [Abstract][Full Text] [Related]
12. Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism. Winer KK; Sinaii N; Peterson D; Sainz B; Cutler GB J Clin Endocrinol Metab; 2008 Sep; 93(9):3389-95. PubMed ID: 18492754 [TBL] [Abstract][Full Text] [Related]
14. Mapping the bimolecular interface of the parathyroid hormone (PTH)-PTH1 receptor complex: spatial proximity between Lys(27) (of the hormone principal binding domain) and leu(261) (of the first extracellular loop) of the human PTH1 receptor. Greenberg Z; Bisello A; Mierke DF; Rosenblatt M; Chorev M Biochemistry; 2000 Jul; 39(28):8142-52. PubMed ID: 10889020 [TBL] [Abstract][Full Text] [Related]
15. Recombinant Human Parathyroid Hormone (1-84): A Review in Hypoparathyroidism. Kim ES; Keating GM Drugs; 2015 Jul; 75(11):1293-303. PubMed ID: 26177893 [TBL] [Abstract][Full Text] [Related]
16. Repurposing a novel parathyroid hormone analogue to treat hypoparathyroidism. Krishnan V; Ma YL; Chen CZ; Thorne N; Bullock H; Tawa G; Javella-Cauley C; Chu S; Li W; Kohn W; Adrian MD; Benson C; Liu L; Sato M; Zheng W; Pilon AM; Yang NN; Bryant HU Br J Pharmacol; 2018 Jan; 175(2):262-271. PubMed ID: 28898923 [TBL] [Abstract][Full Text] [Related]
17. Quality of Life in Hypoparathyroidism. Vokes TJ Endocrinol Metab Clin North Am; 2018 Dec; 47(4):855-864. PubMed ID: 30390818 [TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone therapy for hypoparathyroidism. Cusano NE; Rubin MR; Bilezikian JP Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):47-55. PubMed ID: 25617172 [TBL] [Abstract][Full Text] [Related]
19. Continuous Subcutaneous Recombinant Parathyroid Hormone (1-34) Infusion in the Management of Childhood Hypoparathyroidism Associated with Malabsorption. Saraff V; Rothenbuhler A; Högler W; Linglart A Horm Res Paediatr; 2018; 89(4):271-277. PubMed ID: 28926829 [TBL] [Abstract][Full Text] [Related]
20. Diphtheria Toxin- and GFP-Based Mouse Models of Acquired Hypoparathyroidism and Treatment With a Long-Acting Parathyroid Hormone Analog. Bi R; Fan Y; Lauter K; Hu J; Watanabe T; Cradock J; Yuan Q; Gardella T; Mannstadt M J Bone Miner Res; 2016 May; 31(5):975-84. PubMed ID: 26678919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]